Amgen And Bioeq Shuttle Stelara Biosimilars Into Phase III Trials

Amgen Study Involves FDA-Approved Product

 
• By Dean Rudge
  
Traffic light
Amgen And Bioeq Are Progressing With Biosimilar Stelara Candidates. • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products